Glutathione synthetase deficiency
Rare autosomal recessive disorder impairing glutathione production.
Glutathione synthetase deficiency, or GSD, is a rare inherited metabolic condition caused by mutations in the GSS gene. This gene normally provides instructions for making the enzyme glutathione synthetase, which is essential for the gamma-glutamyl cycle—a process that occurs in most cells and is required to produce glutathione. Glutathione acts as an antioxidant, protecting cells from damage caused by unstable oxygen-containing molecules that arise as byproducts of energy production. It also helps the body process medications and cancer-causing substances, and is involved in building DNA, proteins, and other key cellular components. When the GSS gene is mutated, cells cannot make enough glutathione, leading to the symptoms of the disorder.
The condition follows an autosomal recessive inheritance pattern, meaning a person must inherit two defective copies of the gene—one from each parent—to be affected. Parents who each carry one copy typically show no symptoms.
GSD is classified into three types based on severity. The mild form usually causes hemolytic anemia, or the destruction of red blood cells. In rare cases, affected individuals also excrete large amounts of 5-oxoproline (also called pyroglutamic acid) in their urine, a condition known as 5-oxoprolinuria, which occurs when glutathione is not processed correctly. The moderate form leads to symptoms beginning shortly after birth, including hemolytic anemia, 5-oxoprolinuria, and metabolic acidosis, which is elevated acidity in the blood and tissues. In addition to these features, the severe form can cause neurological problems such as seizures, psychomotor retardation (a general slowing of physical reactions, movements, and speech), intellectual disability, ataxia (loss of coordination), and sometimes recurrent bacterial infections.
As of 2018, there is no cure for GSD. Treatment focuses on managing symptoms and related issues. Sodium bicarbonate is used to treat metabolic acidosis, while antioxidants like vitamins E and C can help reduce oxidative damage.
- Field
- Metabolic disorder
- Known for
- Prevents production of glutathione, leading to hemolytic anemia, metabolic acidosis, and neurological symptoms
- Inheritance
- Autosomal recessive
- Gene
- GSS gene
- Types
- Mild, moderate, severe
Lore & Background
Mutations in the GSS gene cause glutathione synthetase deficiency. This gene provides instructions for making the enzyme glutathione synthetase, which is involved in the gamma-glutamyl cycle necessary for producing glutathione. Glutathione protects cells from damage caused by unstable oxygen-containing molecules that are byproducts of energy production. Mutations in the GSS gene prevent cells from making adequate levels of glutathione, leading to the signs and symptoms of the disorder.
The disorder is inherited in an autosomal recessive pattern, meaning two copies of the defective gene—one from each parent—are required to be born with the disorder. Parents of an affected individual each carry one copy of the defective gene but usually are not affected.
Glutathione synthetase deficiency can be classified into three types: mild, moderate, and severe. Mild cases usually result in hemolytic anemia and rarely 5-oxoprolinuria. Moderate cases may include hemolytic anemia, 5-oxoprolinuria, and metabolic acidosis beginning shortly after birth. Severe cases additionally involve neurological symptoms such as seizures, psychomotor retardation, intellectual disability, ataxia, and sometimes recurrent bacterial infections.
Reader's Guide
Glutathione synthetase deficiency is significant as a rare metabolic disorder that highlights the critical role of glutathione in cellular protection and metabolism. The condition demonstrates how a single enzyme deficiency can disrupt the gamma-glutamyl cycle, leading to a spectrum of clinical manifestations from mild hemolytic anemia to severe neurological impairment. Its classification into mild, moderate, and severe forms illustrates the variable expressivity of genetic disorders. As of 2018, there is no cure, and treatment is restricted to managing symptoms—sodium bicarbonate for metabolic acidosis and antioxidants such as vitamins E and C to reduce oxidative damage. The disorder serves as a model for understanding oxidative stress and the importance of antioxidant systems in human health. Its autosomal recessive inheritance pattern underscores the need for genetic counseling in affected families.
Did You Know?
- Glutathione synthetase deficiency prevents the production of glutathione, an antioxidant that neutralizes harmful molecules from energy production.
- Mutations in the GSS gene cause the disorder by disrupting the gamma-glutamyl cycle.
- The disorder is classified into mild, moderate, and severe types, with severe cases including seizures, intellectual disability, and ataxia.
- As of 2018, there is no cure; treatment focuses on managing symptoms with sodium bicarbonate and antioxidants like vitamins E and C.
More in Disorders causing seizures 1-24
Spotted an error? Know more?
Reader corrections go straight into our review queue. Suggest an edit · How this site is sourced